Quality of Reporting of Randomized Controlled Trials in General Endocrinology Literature

Rios, Lorena P.; Odueyungbo, Adefowope; Moitri, Misha; Rahman, Mohammed O.; Thabane, Lehana

doi:10.1210/jc.2008-0817

Cited by 81 publications

(92 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An overall quality score was calculated based on the sum of 15 selected items [18]. This score has been previously utilized in multiple studies to assess the quality of reporting and has been found to have high inter-rater reliability [29,37].…”

Section: Randomized Controlled Trial Reportingmentioning

confidence: 99%

Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials

Hui

Arthur

Dalal

et al. 2011

Support Care Cancer

View full text Add to dashboard Cite

show abstract

Section: Randomized Controlled Trial Reportingmentioning

confidence: 99%

Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials

Hui

Arthur

Dalal

et al. 2011

Support Care Cancer

View full text Add to dashboard Cite

show abstract

“…We and others have identified deficiencies in the reporting of RCT results. Among them, one of the most common deficiencies is the lack of reporting of key statistical parameters, such as the sample size calculation [1][2][3][4][5], the method in determining random allocation, the use of blinding, and the method of allocation concealment [5].…”

Section: Introductionmentioning

confidence: 99%

Influence of statistician involvement on reporting of randomized clinical trials in medical oncology

Péron¹,

You²,

Gan³

et al. 2013

Anti-Cancer Drugs

View full text Add to dashboard Cite

Ideally, statisticians should be involved in the design, analysis, and reporting of randomized clinical trials (RCTs). This study assessed the impact of a statistician involvement in published medical oncology RCTs between 2005 and 2009. The reporting quality of each publication was rated using the Overall Reporting Quality Score on the basis of either 2001 or 2010 Consolidated Standards of Reporting Trials criteria. A four-question email survey on the statistical design and analysis was sent to the corresponding authors of each trial. Nonresponders were approached a maximum of three times. Overall, 107 responses were received from 357 solicited authors (30%). Corresponding authors from industry-funded RCTs were less likely to respond (51 vs. 65%, P=0.013). The same person was responsible for statistical design and analyses in 47% of cases. Overall, the statistician involved held a PhD (or equivalent) in statistics in most cases. The statisticians responsible for the statistical design and analysis were listed as coauthors in 68 and 81% of RCT manuscripts. There was no statistically significant impact on manuscript reporting quality of the degree of statistician involvement in manuscript preparation. Fewer trials were reported as positive when the responsible statistician was listed as a coauthor. It is possible that RCTs included in this review are in general of higher quality or were more likely to have a greater level of statistician involvement than smaller, single-arm, or unpublished studies. This imbalance could explain the lack of significant difference observed in the Overall Reporting Quality Score between trials where statisticians were listed as coauthors or not.

show abstract

“…An association between industry funding and better reporting quality has been reported by some authors. 23,27,28 Whether industry sponsoring is associated with better trial quality or whether the better reporting quality of RCTs achieved as a result of industry funding outweighs the publication bias associated with industry sponsoring remains an interesting subject that is beyond the scope of our study and requires further exploration. In this study, more trials in the new group were endovascular related.…”

Section: Discussionmentioning

confidence: 96%

Reporting and Methodological Quality of Randomised Controlled Trials in Vascular and Endovascular Surgery

Hajibandeh

Antoniou

Green

et al. 2015

European Journal of Vascular and Endovascular Surgery

View full text Add to dashboard Cite

show abstract

Quality of Reporting of Randomized Controlled Trials in General Endocrinology Literature

Abstract: The quality of RCT reporting in general endocrine literature is suboptimal. We discuss our results, highlight the areas where improvements are needed, and provide some recommendations.

Cited by 81 publications

References 36 publications

Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials

Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials

Influence of statistician involvement on reporting of randomized clinical trials in medical oncology

Reporting and Methodological Quality of Randomised Controlled Trials in Vascular and Endovascular Surgery

Contact Info

Product

Resources

About